Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001

Por Owe, J F, Daltveit, A K, Gilhus, N E
Publicado em 2006

Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.

Por Mygland, A, Aarli, J A, Matre, R, Gilhus, N E
Publicado em 1994

Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study

Por Andersen, J B, Owe, J F, Engeland, A, Gilhus, N E
Publicado no Eur J Neurol (2014)

Increased bacterial antibody titres and IgA deficiency in epileptic patients.

Por Iivanainen, M, Syrjänen, J, Waltimo, O, Valtonen, V V, Gilhus, N E
Publicado em 1987

Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen.

Por Gilhus, N E, Jones, M, Turley, H, Gatter, K C, Nagvekar, N, Newsom-Davis, J, Willcox, N
Publicado em 1995

Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force

Por Titulaer, M. J., Soffietti, R., Dalmau, J., Gilhus, N. E., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Sillevis Smitt, P. A. E., Tanasescu, R., Vedeler, C. A., Voltz, R., Verschuuren, J. J. G. M.
Publicado em 2010